Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting
-
- 辻坂, 勇太
- Center for iPS Cell Research and Application, Kyoto University; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
-
- 羽溪, 健
- Center for iPS Cell Research and Application, Kyoto University; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
-
- 大久保, 周子
- Center for iPS Cell Research and Application, Kyoto University
-
- 伊藤, 亮
- Center for iPS Cell Research and Application, Kyoto University
-
- 木村, 東
- Center for iPS Cell Research and Application, Kyoto University
-
- 成田, 恵
- Center for iPS Cell Research and Application, Kyoto University
-
- 蝶名林, 和久
- Center for iPS Cell Research and Application, Kyoto University; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
- 舟越, 俊介
- Center for iPS Cell Research and Application, Kyoto University; Takeda-CiRA Joint Program (T-CiRA)
-
- Lucena-Cacace, Antonio
- Center for iPS Cell Research and Application, Kyoto University
-
- 豊田, 太郎
- Center for iPS Cell Research and Application, Kyoto University
-
- 長船, 健二
- Center for iPS Cell Research and Application, Kyoto University
-
- 木村, 剛
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
-
- 齊藤, 博英
- Center for iPS Cell Research and Application, Kyoto University
-
- 吉田, 善紀
- Center for iPS Cell Research and Application, Kyoto University; Takeda-CiRA Joint Program (T-CiRA)
この論文をさがす
説明
For regenerative cell therapies using pluripotent stem cell (PSC)-derived cells, large quantities of purified cells are required. Magnetic-activated cell sorting (MACS) is a powerful approach to collect target antigen-positive cells; however, it remains a challenge to purify various cell types efficiently at large scale without using antibodies specific to the desired cell type. Here we develop a technology that combines microRNA (miRNA)-responsive mRNA switch (miR-switch) with MACS (miR-switch-MACS) to purify large amounts of PSC-derived cells rapidly and effectively. We designed miR-switches that detect specific miRNAs expressed in target cells and controlled the translation of a CD4-coding transgene as a selection marker for MACS. For the large-scale purification of induced PSC-derived cardiomyocytes (iPSC-CMs), we transferred miR-208a-CD4 switch-MACS and obtained purified iPSC-CMs efficiently. Moreover, miR-375-CD4 switch-MACS highly purified pancreatic insulin-producing cells and their progenitors expressing Chromogranin A. Overall, the miR-switch-MACS method can efficiently purify target PSC-derived cells for cell replacement therapy.
収録刊行物
-
- Stem Cell Reports
-
Stem Cell Reports 17 (7), 1772-1785, 2022-07-12
Elsevier BV
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1050292782210424064
-
- ISSN
- 22136711
-
- HANDLE
- 2433/274883
-
- PubMed
- 35688152
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB
- Crossref
- KAKEN
- OpenAIRE